ProQR spins out a new RNA biotech focused on CNS diseases
The Dutch biotech ProQR $PRQR is spinning out a new biotech called Amylon which will pursue a pipeline of drugs in the CNS space. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
